AstraZeneca Secures EU Approval for Koselugo to Treat NF1 PN
Alexion, an AstraZeneca rare disease, has received EU approval for Koselugo (selumetinib), its oral, selective MEK inhibitor, to treat symptomatic, inoperable plexiform neurofibromas (PN)...
Guardant Health, Zephyr AI Collab to Advance Cancer Research
Guardant Health and Zephyr AI have formed a strategic partnership to push forward the discovery of new cancer biomarkers and strengthen precision oncology efforts....
Biobeat Report: CDMO Growth in China and USA for 2026
Biobeat report predicts CDMOs in China & USA to see fastest growth – with mAbs, PROTACs, ADCs & sterile filling in demand
AI’s VC funding...
FDA Approves Omvoh by Eli Lilly for Ulcerative Colitis
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved a new single-injection, once-monthly maintenance option (200 mg/2...
Digital Validation and Compliance in Pharma
Digital Validation and Compliance: The Next Step in Pharma Regulation
The pharmaceutical industry stands at a technological crossroads where decades-old validation practices meet transformative digital...
Carbon-Neutral Bioprocessing in Pharmaceuticals
Green Bioprocessing: Towards a Carbon-Neutral Pharmaceutical Industry
The pharmaceutical industry stands at a critical crossroads where innovation meets environmental responsibility. As global awareness of climate...
Precision Fermentation and the Future of Biomanufacturing
Precision Fermentation: Unlocking the Future of Biomanufacturing
The convergence of synthetic biology, advanced fermentation techniques, and computational design has given rise to precision fermentation, a...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...